ArticlePeerJ2025
Bioinformatics-based identification and validation of mitochondria-related genes associated with neonatal sepsis.
Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: While mitochondrial involvement in sepsis has been widely studied, its role in neonatal sepsis (NESE) remains unclear. This study aimed to explore the molecular mechanisms of mitochondrial-related genes (MRGs) in NESE using bioinformatics analysis. Methods: This study utilized neonatal sepsis-related datasets GSE69686 and GSE95233. Differentially expressed genes (DEGs) were identified by comparing NESE and control groups. Subsequently, candidate genes were then selected by intersecting DEGs with MRGs. These candidate genes were further refined using least absolute shrinkage and selection operator (LASSO) regression and the Boruta algorithm to identify potential biomarkers. Expression levels and receiver operating characteristic (ROC) curve analyses of the candidate biomarkers were assessed in both datasets. To further investigate their mechanisms, functional enrichment, immune infiltration, and drug prediction analyses were conducted. Finally, biomarker expression was validated using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Results: A total of 24 candidate genes were obtained by overlapping 579 DEGs and 1,136 MRGs. Conclusions: In this study, six mitochondria-related biomarkers in NESE were identified and preliminarily validated, which may provide novel insights into disease mechanisms and serve as a potential basis for future diagnostic and therapeutic exploration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.